Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RU 58841 (PSK-3841) 是一种雄激素受体拮抗剂,能够促进头发再生。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 163 | 现货 | ||
5 mg | ¥ 358 | 现货 | ||
10 mg | ¥ 519 | 现货 | ||
25 mg | ¥ 863 | 现货 | ||
50 mg | ¥ 1,390 | 现货 | ||
100 mg | ¥ 2,520 | 现货 | ||
500 mg | ¥ 5,920 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 393 | 现货 |
产品描述 | RU 58841 (PSK-3841) is a specific androgen receptor antagonist or anti-androgen; RU 58841(PSK-3841) has a significant effect on hair regrowth. |
激酶实验 | In vitro Protein Kinase, PI3K, and mTOR Assays: PI3Kα, β, and δ proteins are composed of the iSH2 domain of p85 NH2-terminally fused to the full-length protein p110 protein, with the exception of α that also does not contain the last 20 amino acids. PI3Kγ is produced as full-length protein deleted for its first 144 amino acids. All constructs are fused to a COOH-terminal His tag for convenient purification and then cloned into the pBlue-Bac4.5 (for α, β, and δ isoforms) or pVL1393 (for γ isoform) plasmids. The different vectors are then cotransfected with BaculoGold WT genomic DNA using methods recommended by the vendor for production of the respective recombinant baculoviruses and proteins. BEZ235 are tested for their activity against PI3K using a Kinase-Glo assay. The kinase reaction is done in 384-well black plate. Each well is loaded with 50 μL of test items (in 90% DMSO) and 5 μL reaction buffer containing 10 μg/mL PI substrate (l-α-phosphatidylinositol; Avanti Polar Lipids; prepared in 3% octyl-glucoside) and the PI3K proteins (10, 25, 10, and 150 nM of p110α, p110β, p110δ, and p110γ, respectively) are then added to it. The reaction is started by the addition of 5 μL of 1 μM ATP prepared in the reaction buffer and is incubated for either 60 (for p110α, p110β, and p110δ) or 120 min (for p110γ). It is terminated by the addition of 10 μL Kinase-Glo buffer. The plates are then read in a Synergy 2 reader for luminescence detection. |
别名 | 4-[3-(4-羟基丁基)-4,4-二甲基-2,5-二氧代-1-咪唑烷基]-2-(三氟甲基)苯腈, RU58841, PSK-3841, HMR-3841 |
分子量 | 369.34 |
分子式 | C17H18F3N3O3 |
CAS No. | 154992-24-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 66 mg/mL(178.7 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.7075 mL | 13.5377 mL | 27.0753 mL | 67.6883 mL |
5 mM | 0.5415 mL | 2.7075 mL | 5.4151 mL | 13.5377 mL | |
10 mM | 0.2708 mL | 1.3538 mL | 2.7075 mL | 6.7688 mL | |
20 mM | 0.1354 mL | 0.6769 mL | 1.3538 mL | 3.3844 mL | |
50 mM | 0.0542 mL | 0.2708 mL | 0.5415 mL | 1.3538 mL | |
100 mM | 0.0271 mL | 0.1354 mL | 0.2708 mL | 0.6769 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
RU 58841 154992-24-2 Endocrinology/Hormones Androgen Receptor 4-[3-(4-羟基丁基)-4,4-二甲基-2,5-二氧代-1-咪唑烷基]-2-(三氟甲基)苯腈 HMR3841 Inhibitor RU58841 PSK 3841 RU-58841 PSK3841 inhibit PSK-3841 HMR-3841 HMR 3841 inhibitor